Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous levetiracetam versus phenobarbital for neonatal seizures
IRCT20190526043717N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in seizure comparing Intravenous levetiracetam with Phenobarbital (2 arms). Primary endpoints: Recurrent seizure count, Drug side effects and 1 more. Started Jun 2019; status: completed.
02
Drugs
levetiracetamphenobarbital
03
Conditions
seizure
Beyond the preview
Go deeper on IRCT20190526043717N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190526043717N1.